This model is particularly interesting as a constitutively active TβRI, carrying several mutations preventing FKBP12 binding and abolishing receptor kinase activity, has been shown to impair Neu-induced primary breast tumor formation34. The gene discussed is FKBP1A; the disease is breast neoplasm.